Poorly absorbed antibiotics for the treatment of traveler's diarrhea

David N Taylor1

  • 1Department of International Health, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA. david.taylor@salix.com

Insights

Poorly absorbed antibiotics effectively treat traveler's diarrhea with fewer side effects and less risk of resistance. Rifaximin showed comparable efficacy to ciprofloxacin in clinical studies.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Traveler's diarrhea (TD) is a common illness caused by enteric pathogens.
  • Systemically absorbed antibiotics for TD carry risks of adverse effects and resistance development.
  • Poorly absorbed oral antibiotics offer targeted gastrointestinal delivery with reduced systemic exposure.

Purpose of the Study:

  • To review the efficacy and safety of poorly absorbed oral antibiotics for traveler's diarrhea.
  • To compare the impact of poorly absorbed antibiotics on bacterial resistance compared to systemically absorbed agents.

Main Methods:

  • Literature review of clinical studies on poorly absorbed oral antibiotics for TD.
  • Analysis of antibiotic efficacy, tolerability, and potential for resistance development.

Main Results:

  • Poorly absorbed antibiotics deliver high drug concentrations to the gut with minimal systemic effects.
  • Agents like aztreonam, bicozamycin, and rifaximin demonstrated efficacy and good tolerability.
  • Rifaximin was found to be as effective as ciprofloxacin in shortening TD illness duration.

Conclusions:

  • Poorly absorbed oral antibiotics are a viable treatment option for traveler's diarrhea.
  • These agents may pose a lower risk for promoting bacterial resistance.
  • Further research is needed for invasive infections and comprehensive resistance assessment.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drug Absorption: Factors Affecting GI Absorption01:19

Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...